Model
Edge
EyePoint Pharmaceuticals Inc.
0002013623
Filing Type
3
Filing Date
3/3/2024
Updated
3/4/24, 10:37 AM
Filing
3
Earnings Release
Exhibits
3
Initial Statement of Beneficial Ownership